-
Publication Venue For
-
Updates on LI-RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI..
57:1641-1654.
2023
-
Abbreviated MRI Protocols in the Abdomen and Pelvis.
2023
-
Scanner-Independent MyoMapNet for Accelerated Cardiac MRI T1 Mapping Across Vendors and Field Strengths.
2023
-
A Faster Prostate MRI: Comparing a Novel Denoised, Single-Average T2 Sequence to the Conventional Multiaverage T2 Sequence Regarding Lesion Detection and PI-RADS Score Assessment.
2023
-
Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas..
57:308-317.
2023
-
Pediatric 129 Xe Gas-Transfer MRI-Feasibility and Applicability..
56:1207-1219.
2022
-
Modifying LI-RADS on Gadoxetate Disodium-Enhanced MRI: A Secondary Analysis of a Prospective Observational Study..
56:399-412.
2022
-
Editorial for "Perfusion and Permeability Magnetic Resonance Imaging (MRI) Predicts Future Cavernous Angioma Hemorrhage and Growth"..
55:1450-1451.
2022
-
Recent Advances in Radio-Frequency Coil Technologies: Flexible, Wireless, and Integrated Coil Arrays..
55:1026-1042.
2022
-
Data-Driven Modification of the LI-RADS Major Feature System on Gadoxetate Disodium-Enhanced MRI: Toward Better Sensitivity and Simplicity..
55:493-506.
2022
-
Visualization of Human Aortic Valve Dynamics Using Magnetic Resonance Imaging with Sub-Millisecond Temporal Resolution..
54:1246-1254.
2021
-
Magnetic Resonance Lymphangiography of the Central Lymphatic System: Technique and Clinical Applications..
53:374-380.
2021
-
DTI Tract-Based Quantitative Susceptibility Mapping: An Initial Feasibility Study to Investigate the Potential Role of Myelination in Brain Connectivity Change in Cerebral Palsy Patients During Autologous Cord Blood Cell Therapy Using a Rotationally-Invariant Quantitative Measure..
53:251-258.
2021
-
Editorial for "Harmonization of Quantitative Parenchymal Enhancement in T1-Weighted Breast MRI"..
52:1383-1384.
2020
-
Chronic Thromboembolic Pulmonary Hypertension Perioperative Monitoring Using Phase-Resolved Functional Lung (PREFUL)-MRI..
52:610-619.
2020
-
PI-RADS: Past, present, and future..
52:33-53.
2020
-
Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approach..
51:1630-1640.
2020
-
Illuminating Lung Inflammation at the Alveolar Capillary Interface..
51:1677-1678.
2020
-
An update for LI-RADS: Version 2018. Why so soon after version 2017?.
50:1990-1991.
2019
-
User and system pitfalls in liver imaging with LI-RADS..
50:1673-1686.
2019
-
Building blocks for thoracic MRI: Challenges, sequences, and protocol design..
50:682-701.
2019
-
Machine learning-based prediction of future breast cancer using algorithmically measured background parenchymal enhancement on high-risk screening MRI..
50:456-464.
2019
-
Association of distant recurrence-free survival with algorithmically extracted MRI characteristics in breast cancer..
49:e231-e240.
2019
-
Recommendations towards standards for quantitative MRI (qMRI) and outstanding needs..
49:e26-e39.
2019
-
Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease..
49:1456-1466.
2019
-
Deep learning in radiology: An overview of the concepts and a survey of the state of the art with focus on MRI..
49:939-954.
2019
-
LI-RADS 2017: An update..
47:1459-1474.
2018
-
Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?.
46:1332-1340.
2017
-
Respiratory motion artifacts during arterial phase imaging with gadoxetic acid: Can the injection protocol minimize this drawback?.
46:1107-1114.
2017
-
Liver imaging reporting and data system category 4 observations in MRI: Risk factors predicting upgrade to category 5..
46:783-792.
2017
-
Gadolinium-based contrast agents: A comprehensive risk assessment..
46:338-353.
2017
-
Comparison of ferumoxytol-enhanced MRA with conventional angiography for assessment of severity of transplant renal artery stenosis..
45:779-785.
2017
-
Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?.
45:646-659.
2017
-
Breast MRI radiogenomics: Current status and research implications..
43:1269-1278.
2016
-
How reader perception of capsule affects interpretation of washout in hypervascular liver nodules in patients at risk for hepatocellular carcinoma..
43:1337-1345.
2016
-
Systematic review and meta-analysis of the accuracy of MRI to diagnose appendicitis in the general population..
43:1346-1354.
2016
-
Can combining triple-arterial phase acquisition with fluoroscopic triggering provide both optimal early and late hepatic arterial phase images during gadoxetic acid-enhanced MRI?.
43:1073-1081.
2016
-
Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm..
42:1281-1290.
2015
-
Computational approach to radiogenomics of breast cancer: Luminal A and luminal B molecular subtypes are associated with imaging features on routine breast MRI extracted using computer vision algorithms..
42:902-907.
2015
-
MRS measured fatty acid composition of periprostatic adipose tissue correlates with pathological measures of prostate cancer aggressiveness..
42:651-657.
2015
-
Concordance of hypervascular liver nodule characterization between the organ procurement and transplant network and liver imaging reporting and data system classifications..
42:305-314.
2015
-
Magnetic resonance histology..
42:1-2.
2015
-
On confirmation bias in imaging research..
41:1163-1164.
2015
-
Emerging applications for ferumoxytol as a contrast agent in MRI..
41:884-898.
2015
-
Principles of T2 *-weighted dynamic susceptibility contrast MRI technique in brain tumor imaging..
41:296-313.
2015
-
Respiratory-gated noncontrast SPACE MR angiography sequence at 3T for evaluation of the central veins of the chest: a feasibility study..
41:67-73.
2015
-
CME update: review articles and commentaries in JMRI..
40:778.
2014
-
Cerebrovascular reactivity mapping in patients with low grade gliomas undergoing presurgical sensorimotor mapping with BOLD fMRI..
40:383-390.
2014
-
Retrospective assessment of the utility of an iron-based agent for contrast-enhanced magnetic resonance venography in patients with endstage renal diseases..
40:113-118.
2014
-
Impact of precontrast T10 relaxation times on dynamic contrast-enhanced MRI pharmacokinetic parameters: T10 mapping versus a fixed T10 reference value..
39:1136-1145.
2014
-
Physiorack: an integrated MRI safe/conditional, gas delivery, respiratory gating, and subject monitoring solution for structural and functional assessments of pulmonary function..
39:735-741.
2014
-
Validation of sub-segmental visual scoring for the quantification of ischemic and nonischemic myocardial fibrosis using late gadolinium enhancement MRI..
38:1369-1376.
2013
-
The evolving landscape of self-assessment continuing medical education (SA-CME)..
38:509-510.
2013
-
Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model..
38:329-335.
2013
-
Hepatocellular carcinoma in a North American population: does hepatobiliary MR imaging with Gd-EOB-DTPA improve sensitivity and confidence for diagnosis?.
37:398-406.
2013
-
Reproducibility of single-subject fMRI language mapping with AMPLE normalization..
36:569-580.
2012
-
Function biomedical informatics research network recommendations for prospective multicenter functional MRI studies..
36:39-54.
2012
-
Liver MRI in the hepatocyte phase with gadolinium-EOB-DTPA: does increasing the flip angle improve conspicuity and detection rate of hypointense lesions?.
35:611-616.
2012
-
Pulmonary kinematics from tagged hyperpolarized helium-3 MRI..
31:1236-1241.
2010
-
Accelerating non-contrast-enhanced MR angiography with inflow inversion recovery imaging by skipped phase encoding and edge deghosting (SPEED)..
31:757-765.
2010